sur ABIVAX (EPA:ABVX)
JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX
On April 13, 2026, ABIVAX announced that JP Morgan Chase & Co., through its subsidiaries, had crossed the 5% threshold of voting rights in the company, now holding 5.23% of the share capital and 5.07% of the voting rights. This acquisition was made through JP Morgan Securities LLC, JP Morgan Securities plc, and JP Morgan Chase Bank.
This increase in shareholding primarily results from the purchase of ABIVAX shares by way of assimilation, including custody contracts and share swaps. JP Morgan Securities LLC and JP Morgan Securities plc specified their holdings through various financial instruments, such as equity swaps and call options, with maturities ranging from 2026 to 2033.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX